Rick Simpson Oil (RSO) in Jackson County, Colorado: The Complete Guide by OilWell Cannabis

For Jackson County Ranchers, Veterans, and Every Neighbor Seeking Honest Cannabis Medicine

Jackson County isn’t like the rest of Colorado. While Denver gets the headlines and the Front Range gets the dispensaries on every corner, we know what it’s like to live where the pavement ends. Out here in North Park, where the Medicine Bow-Routt National Forest meets the Wyoming border, where ranch work starts before sunrise and doesn’t stop when the sun sets, where winters test your resilience and altitude tests your lungs — we understand that “access to medicine” means more than having a store nearby. It means having something you can trust, something that works, and something that won’t leave you impaired when there’s still work to be done.

This guide is written specifically for you: the Jackson County residents of Walden, Cowdrey, Rand, and Gould. The ranchers tending cattle across 1,600 square miles of high-altitude prairie. The veterans who’ve served our country and come home to the quiet of North Park. The folks dealing with chronic pain from decades of physical labor in conditions that would break most people. The ones who’ve driven two hours to Steamboat Springs or three hours to Fort Collins for relief, only to find products that don’t match their values or their needs.

We’re OilWell Cannabis. We’re not from Jackson County — we’re from Houston, Texas, where we built our company on the same principles that matter here: integrity, community, and putting people before profit. We’ve spent years researching, formulating, and perfecting a modern evolution of Rick Simpson Oil that honors the original vision while fixing the problems that made traditional RSO dangerous. And we’re publishing everything — every cannabinoid amount, every terpene, every piece of research — because that’s what we learned growing up in places where trust is earned, not given.

ABOUT RICK SIMPSON AND TRADITIONAL RICK SIMPSON OIL

Who is Rick Simpson — And Why His Story Matters to Jackson County

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor, scientist, or medical professional. He was a power engineer and maintenance worker — a blue-collar tradesman who understood machines, hard work, and what it means when the system fails you. Sound familiar? That’s a story we hear all the time in Jackson County.

In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. The medications he was prescribed either failed to help or made things worse. When he asked his physician to consider cannabis, the doctor refused.

Important context: This is exactly the position many Jackson County residents find themselves in. You’ve been to the clinic in Walden. You’ve seen the specialist in Steamboat. You’ve tried the prescriptions. Maybe they helped a little, maybe they didn’t, or maybe the side effects were worse than the condition itself. When you’re told there’s nothing more that can be done, you start looking for alternatives. That’s human nature, and it’s where Rick Simpson’s story begins.

Simpson’s interest deepened after learning about a 1974 study funded by the National Institute of Health at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. That study — originally intended to demonstrate harm — became a foundational reference for his later advocacy, even though its findings were never replicated in controlled human cancer trials.

The pivotal moment came in 2003. Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and claimed they disappeared within four days. No independent medical verification of this outcome has ever been published. No biopsy confirmation. No clinical follow-up in any peer-reviewed source.

Important context: Simpson’s account is personal testimony, not medical evidence. The absence of clinical documentation means these events cannot be evaluated as scientific proof. They are, however, historically significant as the catalyst for a global movement. In Jackson County, where word-of-mouth travels fast and personal experience carries weight, we understand why this story resonates. But we also understand the difference between a powerful narrative and proven medicine.

The Crusade — Spreading the Oil

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free to cancer patients and others in his community. He charged nothing. By his account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, directed by Christian Laurette. The film documented his claims, showed testimonials from people he treated, and framed his work as a grassroots challenge to pharmaceutical interests. Distributed freely online, it became one of the most widely shared cannabis advocacy films of its era. For many people, it was their introduction to concentrated cannabis oil as medicine.

Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police raided his property in 2005 and again in 2009. He was charged with cultivation, possession, and trafficking, and eventually left Canada for Europe, living in Croatia and later the Netherlands, where he continued his advocacy from abroad.

In 2012, Simpson published Phoenix Tears: The Rick Simpson Story, detailing his experience, oil-making process, and philosophical views. He maintained phoenixtears.ca as his primary platform for information and advocacy.

Throughout his public career, Simpson’s position remained consistent: he maintained that cannabis oil could cure cancer and many other diseases, and that pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge to protect financial interests.

Important context: Simpson’s conspiratorial framing reflects a worldview shared by many in the early cannabis movement. In Jackson County, where pharmaceutical distrust runs deep after the opioid crisis and where many feel the medical system has failed rural communities, we understand why this resonates. But our commitment is to evidence, not ideology.

The Traditional RSO Protocol — Simpson’s 60-Gram, 90-Day Regimen

Simpson’s core treatment recommendation was to consume 60 grams of concentrated cannabis oil over approximately 90 days. He considered this the minimum necessary for serious cancer treatment.

Goal

Consume 60 grams of concentrated, high-THC cannabis oil over roughly 90 days.

Titration Schedule

• Week 1: Begin with a dose the size of half a grain of dry rice — roughly 10-15 milligrams — taken three times daily. Total daily intake: approximately 30-45 milligrams.
• Weeks 2-5: Double the dose every four days to build tolerance gradually. By week five, the target is approximately 1 gram (1,000 milligrams) per day, divided into three doses.
• Weeks 5-12: Maintain 1 gram per day, divided into three 333-milligram doses, until all 60 grams are consumed.

Administration Methods

• Primary — oral: Place dose under tongue (sublingual) or swallow. Simpson considered this essential for systemic absorption and treating internal cancers.
• Secondary — topical: Apply directly to skin cancers and lesions, cover with bandage, change every 3-4 days. He combined topical with oral dosing for skin cancers.
• Not recommended — inhalation: Simpson didn’t recommend smoking or vaporizing as primary treatment, though he acknowledged it for immediate symptom relief.

Tolerance and Psychoactive Effects

• Simpson claimed patients develop significant tolerance to THC’s psychoactive effects within 3-4 weeks.
• He considered the high a minor, temporary side effect and urged patients not to let it discourage them.
• Recommended initial doses at night to sleep through early effects.
• Warned against driving or operating machinery during titration.

Post-Protocol Maintenance

After completing 60 grams, Simpson recommended 1-2 grams per month indefinitely for long-term health and cancer prevention.

Dietary and Lifestyle Recommendations

Simpson advocated reducing sugar, avoiding processed foods, and improving nutrition, though he wasn’t systematic about dietary protocols.

Important Context for Evaluating This Protocol

This protocol was designed by one person based on personal experience. It was not developed through clinical trials, dose-finding studies, or formal research. Critical points for Jackson County residents:

• No controlled trial validation. There are no published randomized controlled trials, cohort studies, or well-documented case series evaluating this specific 60-gram/90-day protocol for any condition.
• Assumes crude, unstandardized material. The 60-gram quantity assumes a single-strain, THC-dominant extract with no standardized potency. Actual THC content varied widely.
• Very high THC exposure. At peak dosing, patients consumed roughly 1 gram of high-THC oil daily. Assuming 60-90% THC, that’s 600-900 milligrams of delta-9 THC per day — far exceeding anything studied in controlled settings. For context, FDA-approved dronabinol is typically dosed at 2.5-20 milligrams per day.
• Real risks at these doses. Consuming 600-900 mg THC daily carries serious risks: severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder. These risks are well-documented in our General Knowledge section.
• Oncology context. Patients with active cancer are medically complex. Using unregulated, unstandardized cannabis oil as primary treatment — potentially in place of proven therapies — introduces harm beyond the oil itself.

What is Traditional Rick Simpson Oil — The Product

Traditional RSO refers to the specific oil Simpson made, defined by his method rather than lab specifications.

Source Material

Simpson used high-THC, indica-dominant cannabis strains. He specifically favored heavy, sedating indicas and recommended against sativas for cancer treatment. He grew his own cannabis or sourced from trusted growers. There was no strain standardization — starting material varied by availability and growing season.

Extraction Solvent

Simpson originally used naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol. Neither is food-grade. He warned against butane or acetone due to safety concerns.

Extraction Process

1. Place dry or semi-dry cannabis in a bucket
2. Cover with solvent, agitate for several minutes
3. Pour through filter (cheesecloth) into collection vessel
4. Repeat with fresh solvent on same plant material
5. Place combined solvent washes in rice cooker
6. Evaporate solvent at relatively low heat
7. Thick, dark oil remains at bottom
8. Transfer to oral syringes for storage and dosing

Appearance and Physical Characteristics

Traditional RSO was nearly black, thick, viscous, tar-like oil with strong cannabis odor and possible solvent-residual smell. It was sticky and difficult to handle at room temperature.

Cannabinoid Profile

• Primarily decarboxylated delta-9 THC. Heat converted essentially all THCa to delta-9 THC. Traditional RSO was an activated, THC-dominant product.
• Naturally occurring minor cannabinoids. Whatever CBD, CBN, CBC, CBG the source strain contained were present at natural ratios, but not controlled, measured, or targeted.
• No ratio control. Profile was entirely determined by source plant genetics and growing conditions.
• Estimated THC content. Likely 60-90% total THC by weight, though never lab-verified in traditional production.

Terpene Content

Minimal to none. Solvent extraction and high-heat evaporation stripped terpenes. Traditional RSO was effectively a cannabinoid-only product.

Standardization and Testing

None. Every batch differed based on starting material, growing conditions, solvent purity, extraction technique, evaporation temperature/duration, and individual maker’s process. No Certificate of Analysis, no cannabinoid quantification, no contaminant screening.

Residual Solvent Risk

This is one of the most significant safety concerns. Naphtha is a complex petroleum hydrocarbon mixture that may contain benzene, toluene, xylene, and other toxic compounds. Isopropyl alcohol, while cleaner, is also not intended for internal consumption. Incomplete solvent purging — very difficult to verify without lab testing — leaves potentially harmful residues.

Modern extraction uses food-grade ethanol or supercritical CO₂ specifically to address this problem.

Simpson’s Claims vs. The Evidence Record

Rick Simpson made expansive therapeutic claims: RSO could cure cancer (including terminal cases) and was effective against diabetes, chronic pain, infections, glaucoma, arthritis, depression, insomnia, multiple sclerosis, and more. He was adamant and consistent about these claims throughout his advocacy career.

What Simpson Was Not

Simpson was not a scientist, physician, pharmacologist, or researcher. He had no formal training in medicine, oncology, pharmacology, or clinical research methodology. He never designed, conducted, funded, or published a clinical trial. He never submitted results to peer review. His entire evidence base consisted of personal experience, self-reported patient outcomes, and informal testimonials — with no controls, no independent verification, no imaging confirmation, no long-term follow-up, and no blinding.

What the Preclinical Literature Shows

The preclinical cannabinoid-cancer literature exists and is scientifically interesting:

• In vitro studies show THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines
• Animal models show some tumor-growth inhibition in mice and rats

What the Preclinical Literature Does Not Show

• These findings have not translated into proven human cancer cures. The gap between in vitro/animal results and human clinical outcomes is vast.
• No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer.
• Small human trials of cannabinoids in cancer contexts (particularly glioblastoma) have been exploratory and small, not producing results that support cancer-cure claims.

Institutional Positions

• U.S. National Cancer Institute (NCI): Acknowledges cannabinoids have been studied for potential anticancer effects in laboratory and animal models but does not endorse cannabis or cannabis oil as cancer treatment.
• U.S. Food and Drug Administration (FDA): Has not approved any cannabis plant product for cancer treatment. Only FDA-approved cannabinoid-related products are for specific indications: Epidiolex (CBD) for certain seizure disorders and dronabinol/nabilone (synthetic THC analogues) for chemotherapy-related nausea and AIDS-related wasting.
• Health Canada: Has never approved RSO or cannabis oil as cancer cure.
• NCCIH: States strongest cannabinoid evidence is for rare epilepsies, chemotherapy-related nausea/vomiting, and appetite/weight-loss indications in HIV/AIDS — not cancer cure.

What Simpson Got Right

Simpson drew attention to cannabinoids as a serious biomedical research area when the world was ignoring or suppressing that conversation. His advocacy helped create political, cultural, and social conditions for the legal cannabis industry and cannabinoid research infrastructure that exists today. He was among the first to bring concentrated cannabis oil to widespread public awareness, and the term RSO remains the most recognized name for full-spectrum cannabis extract.

What He Overstated

The leap from preclinical signals to cancer cure was not supported by human evidence when Simpson made it, and it’s not supported now. Encouraging patients — particularly cancer patients — to rely on RSO as primary treatment in place of proven oncologic therapies (surgery, radiation, chemotherapy, immunotherapy) carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern in alternative-medicine literature. Simpson’s absolute certainty about curative claims exceeded what the evidence could support and still exceeds it today.

Traditional RSO vs. Modern Formulated RSO

The following table summarizes key differences between traditional RSO and OilWell’s modern approach.

Dimension	Traditional RSO	OilWell Formulated RSO
Source Material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction Method	Naphtha or isopropyl alcohol	Modern food-grade ethanol or CO₂ methods
Cannabinoid Profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene Content	Destroyed by high-heat process	Live terpenes at 5% with defined seven-terpene profile
Standardization	None — every batch different	Lab-tested with specific mg/mL targets
Lab Testing	Not available or performed	Full panel testing
Residual Solvents	Significant risk with naphtha	Controlled and tested
Dosing Precision	Approximate, syringe-based	Measured per mL with known content (553 mg/mL)
Product Formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa Preservation	No — fully decarboxylated by heat	Yes — THCa included as separate ingredient at 1,500 mg
Evidence Approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge from Traditional RSO

Our formulations are not traditional RSO. They are informed by the tradition but depart deliberately:

Multi-cannabinoid approach. Traditional RSO relied on whatever single strain the maker grew. Our formulas intentionally include seven cannabinoids — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — because entourage-effect literature suggests potential benefit from cannabinoid diversity, even though robust clinical proof of whole-formula synergy remains limited [20][29].

Terpene preservation and addition. Traditional RSO had essentially no terpene content. We include live terpenes at 5% with a specific seven-terpene profile: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Terpene bioactivity is plausible and supported at preclinical level, even if human clinical confirmation for cannabis-specific terpene effects is still developing [20][21][23][24][25][26][27][28][29].

THCa as a separate ingredient. Traditional RSO fully decarboxylated everything. Our sublingual formula includes THCa at 1,500 mg as a distinct ingredient, preserving the acidic precursor because THCa literature suggests potentially relevant non-psychoactive bioactivity that is lost when THCa converts to THC [12].

Reduced delta-9 THC dominance. Traditional RSO was 60-90% delta-9 THC. Our sublingual formula uses delta-9 THC at only 90 mg while incorporating delta-8 THC at 6,000 mg and distributing remaining cannabinoids across CBD (4,500 mg), CBG (3,000 mg), CBN (750 mg), and CBC (750 mg).

Product format innovation. Simpson envisioned only one format: oral oil from a syringe. We offer both a 30 mL sublingual oil and a 1-gram vape cartridge, each with format-specific formulation acknowledging different pharmacokinetic profiles [14].

Solvent Safety and Extraction Evolution

Traditional RSO used naphtha or isopropyl alcohol — neither food-grade. Naphtha is a complex petroleum hydrocarbon mixture that may contain benzene, toluene, xylene, and other toxic compounds. Incomplete solvent purging — very difficult to verify without analytical chemistry — leaves potentially harmful residues.

Modern cannabis extraction overwhelmingly uses food-grade ethanol or supercritical CO₂. These methods allow more complete solvent removal, and finished products can be tested for residual solvents using validated analytical methods like headspace gas chromatography. This is one of the most straightforward improvements the modern regulated cannabis industry has made over traditional RSO production.

This evolution connects directly to our product-quality discussion: product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, and dose variability all materially affect interpretation in real-world products [1][10][11][14].

The Decarboxylation Question

Traditional RSO was fully decarboxylated. The heat involved in evaporating solvent — typically sustained at or near solvent boiling point (60-80°C for naphtha, 82°C for isopropyl alcohol) — converted essentially all THCa into delta-9 THC. This meant acidic cannabinoids that exist abundantly in raw cannabis (THCa, CBDa, CBGa) were lost as distinct compounds.

Our sublingual formula deliberately preserves THCa at 1,500 mg as a separate ingredient. This is an intentional choice informed by THCa evidence: THCa itself does not produce psychoactive effects associated with THC, but its interpretation depends on route, temperature, processing, and storage because THCa can convert to THC under heating or over time [12].

Terpene Loss in Traditional RSO

Terpenes are volatile aromatic compounds with relatively low boiling points (21-157°C). Most abundant terpenes like myrcene, limonene, and pinene volatilize below 180°C. Traditional RSO production destroyed terpenes in two ways: solvent extraction dissolved them, and high-heat evaporation volatilized them.

This meant traditional RSO was essentially cannabinoid-only, despite being derived from terpene-rich plant. Whatever aromatic, flavoring, or potentially bioactive terpene compounds the source cannabis contained were lost.

Our formulas specify live terpenes at 5% with a defined seven-terpene profile: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Each terpene has its own evidence profile. Entourage-effect literature [20][29] provides theoretical framework for why preserving and including terpenes alongside cannabinoids may matter pharmacologically, even though robust human clinical proof of cannabis-specific entourage effects remains limited.

Evidence Standards Then and Now

Rick Simpson operated in a pre-legalization, pre-lab-testing era. When he began making oil in early 2000s, cannabis was illegal in Canada and most of the world. There was no regulatory framework, no standardized testing, no legal pathway for clinical research, and no peer-reviewed journals dedicated to cannabis therapeutics. The cannabis underground was the only access point, and personal experience was primary evidence currency.

Simpson’s methods reflected those constraints. His evidence was anecdotal. His production was unstandardized. His claims were untested in any formal sense. This is not necessarily moral failing — it’s description of environment.

This document takes fundamentally different approach. Our General Knowledge section applies formal evidence hierarchy: human clinical evidence first, then systematic reviews and meta-analyses, then institutional summaries, then preclinical and mechanistic literature [1]-[29]. Every compound-level claim is tied to specific peer-reviewed sources with evidence strength clearly labeled. We honor historical origin of RSO while committing to standards of modern cannabinoid science. Where Simpson relied on personal testimony, we rely on published literature and institutional sources.

ABOUT OILWELL CANNABIS AND THE OILWELL RSO FORMULA

The Origin of OilWell Cannabis

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen, Texas — right across the river from Reynosa, Tamaulipas, Mexico, in what they call the Borderplex. The McAllen-Reynosa area is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. McAllen is a city of contrasts — vibrant culture and thriving retail, yet deeply affected by poverty and limited opportunities outside retail and healthcare. Reynosa is an industrial hub plagued by violence and cartel activity.

Colin’s childhood was marked by exposure to both opportunities and challenges of life along the border. Early on, he learned to hustle, taking on risky work transporting items across the border. Those experiences exposed him to complexities and dangers. A lot of his best friends have been killed or are in prison because of associated dangers. He has faced every form of violence imaginable, both in streets and across border. By sixteen, he had to leave home for good.

Despite dangers, Colin did not fall into darkest paths like selling harder substances. Instead, he focused on cannabis, seeing it as safer and more beneficial alternative. He grew up in traditional cannabis world long before legalization, learning plant intimately while operating in shadows. Over time, he transitioned from early risky ventures to creating legal, legitimate business in industry he believes in.

Colin later became formally trained software engineer and did custom development work for Baylor College of Medicine, one of most prestigious medical institutions in Texas Medical Center. That combination — deep cannabis plant knowledge plus medical-grade technical precision — defines OilWell’s approach.

Bentley’s Story — The Foundation of Everything

The company’s origin begins with a dog named Bentley. Bentley was more than a pet — he was family, companion who stood by Colin through toughest times. When Bentley fell seriously ill, veterinarians delivered verdict no pet owner wants: euthanasia was only humane option. Bentley was paralyzed in his back legs. They said pain medications would destroy his internal organs, causing more pain and suffering. Choice was painful prolonged decline or immediate mercy killing.

But giving up on Bentley was not option. Colin had already faced too much loss and seen too much suffering. Bentley was fighter, just like him, and Colin was not ready to let him go. In desperate search for alternatives, he stumbled upon healing properties of CBD through question that changed everything.

A kind-hearted rescue worker named Jessica asked Colin: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had cannabis experience — but it was recreational, getting high. He had never explored therapeutic applications. Jessica’s question exposed blind spot that became mission.

Determined to save Bentley, Colin learned to create CBD golden paste — specialized cannabinoid formula for pets. It was not cure, but it was lifeline — and it was hope. And that hope delivered something veterinary medicine said was impossible: Bentley got up. He walked over to Colin and brought him his ball to play. It was miracle. From paralyzed and facing euthanasia to fetching his ball. This was not placebo effect — dogs do not respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced:

• Neurodegeneration led him to understand CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia led him to CBC’s role in neurogenesis
• Glaucoma led him to THC’s CB1 agonism for intraocular pressure reduction
• Crippling arthritis led him to develop multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. CBD alone could not address neurodegeneration and dementia and glaucoma and arthritis simultaneously. Minor cannabinoids like CBG, CBN, and CBC became critical as Bentley aged. Pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork.

Colin’s Personal Journey — From PTSD to Formulation

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey — notoriously difficult and dangerous — using cannabinoid knowledge he developed keeping Bentley alive.

The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, OilWell also offers Peace Gummies formula in vape form, which Colin personally uses to manage his insomnia and severe PTSD on ongoing basis. This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, discovery that cannabinoids work when pills do not.

Over time, therapeutic benefits Colin first discovered through efforts to save Bentley became core of his work. He has developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

ABC13 Recognition — Houston’s Cannabis Authority

ABC13 KTRK Houston — Houston’s number-one news source — featured Colin and OilWell Cannabis in seven comprehensive news segments spanning 2019 to 2023, covering Texas marijuana law, Delta-8 legal analysis, COVID-19 community health leadership, criminal justice reform, and cannabis business pioneering. Colin was repeatedly selected as primary industry expert for cannabis policy and product coverage in America’s fourth-largest city.

Colin’s quote from first ABC13 feature in September 2019 captures OilWell philosophy: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

Current Operations — Real Business, Real Credentials

Today, OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). The company has operated since 2019, generates approximately one million dollars in annual revenue, maintains near-5.0 Google rating, and is Texas DSHS licensed.

All OilWell products are carefully crafted with personal touch, from artwork on packaging to formulations inside. All artwork, formulations, and packaging are created in-house in Houston, using only OilWell’s own recipes and ideas. Colin brings Houston grit, McAllen roots, and builder’s mindset to company, but posture stays simple: make products with intent, answer directly, and never pretend cannabis is right for everyone.

The OilWell RSO Philosophy

OilWell’s RSO is not traditional Rick Simpson Oil. It is formulated, multi-cannabinoid product informed by RSO tradition but departing deliberately to solve problems that limited Rick Simpson’s original vision.

Four core principles define our approach, each aligning with and evolving Simpson’s ethos:

1. Accessibility over gatekeeping. No medical card required. Anyone age twenty-one or older can purchase. We ship nationwide across United States and internationally to customers who verify local legality. Simpson believed medicine should be accessible to everyone; we built product and distribution model that makes that accessible legally. For Jackson County residents living 90 miles from the nearest major dispensary, this accessibility is critical.

2. Patient-controlled potency. THCa is sold in its acidic, non-psychoactive form. Customer decides whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their medicine; we engineered product that puts that control in customer’s hands through chemistry rather than rhetoric. For Jackson County ranchers who need daytime function for cattle work, this control is essential.

3. Open-source formulas. We publish complete formulas publicly — every cannabinoid, every milligram amount, every percentage — so anyone who cannot afford product can source ingredients and make their own version. Simpson gave his oil away free and taught people how to make it; we adapted that ethos for modern cannabinoid marketplace by selling professionally manufactured product and publishing recipe. For Jackson County’s DIY, self-sufficient ranching community, this open-source approach aligns with your values.

4. Evidence-informed, not evidence-overstating. Our General Knowledge section represents commitment to honest education about what science actually says. Simpson operated without access to peer-reviewed literature; we have that access and use it to distinguish what is well-supported, what is emerging, and what is overstated.

Farm Bill Compliance and THCa Legal Framework

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at federal level. This legal framework is foundation of OilWell’s RSO product design.

Our RSO Sublingual Oil contains only 90 milligrams delta-9 THC in entire 30 mL bottle — 3 milligrams per milliliter — well under 0.3% threshold. All cannabinoids are hemp-derived. Product is legal under federal law and in Colorado.

For Jackson County residents: Colorado has legal recreational cannabis, but that doesn’t mean all products are created equal. Our Farm Bill-compliant formula means you can legally receive shipments via USPS to your Walden PO Box or ranch address without concern about state vs. federal conflict. Colorado law allows adults 21+ to possess cannabis products, and our products meet all federal shipping requirements.

THCa — tetrahydrocannabinolic acid — is acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at point of sale because it has not been converted to delta-9 THC.

Customer can legally decarboxylate THCa into delta-9 THC at home by heating oil at 260°F (125°C) for 45-60 minutes in oven-safe glass container. This converts 1,500 milligrams THCa into approximately 1,315 milligrams delta-9 THC. Combined with existing 90 milligrams delta-9 THC in formula, this produces approximately 1,405 milligrams total delta-9 THC — giving product psychoactive potency comparable to traditional illegal RSO, entirely at customer’s discretion after purchase.

Important legal notice for Jackson County: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with local laws regarding cannabinoid products. Colorado law allows personal possession and decarboxylation of hemp products for personal use. OilWell ships with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal responsibility.

Open-Source Formulas — Why We Publish Everything

We publish complete RSO formulas — every cannabinoid, every milligram amount, every percentage — in public documents including this one. Our RSO Sublingual Oil formula and RSO Vape Cartridge formula are detailed in full later in this document.

Rationale is straightforward: if someone cannot afford our products ($129.99 for sublingual oil, $49.99 for vape cartridge), they can see exactly what formula contains, source individual cannabinoid distillates and isolates, and make their own version. The formulas in this document are the open-source formulas.

This is direct echo of Rick Simpson’s original ethos. He gave his oil away free and taught people how to make it. He never patented his method. He never charged patients. We adapted that ethos for modern cannabinoid marketplace: we sell professionally manufactured, lab-tested, standardized product for those who want it, and we publish complete recipe for those who want to make it themselves.

As Colin said on ABC13 in 2019: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

The Decarboxylation Choice — Patient-Controlled Potency

Traditional RSO was always fully decarboxylated. Heat of solvent evaporation converted all THCa to delta-9 THC, leaving patient with no choice about psychoactivity — oil was always psychoactive.

Our sublingual formula contains 1,500 milligrams THCa in acidic, non-psychoactive form. This creates three distinct usage options:

Option 1 — Raw, no heat. All 1,500 milligrams stays as THCa — completely non-psychoactive. THCa evidence profile describes potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. This option is compatible with work, driving, and daytime use with zero psychoactive impairment. Perfect for Jackson County ranchers who need to stay sharp for cattle checks and equipment operation.

Option 2 — Fully activated, home decarboxylation. Heating oil at 260°F for 45-60 minutes converts 1,500 milligrams THCa into approximately 1,315 milligrams delta-9 THC. Combined with existing 90 milligrams delta-9 THC, this yields approximately 1,405 milligrams total delta-9 THC. Combined with 6,000 milligrams delta-8 THC, activated product achieves psychoactive potency comparable to traditional high-THC RSO — 100% legally, because decarboxylation occurs at customer’s discretion after purchase. Customer may also transfer controlled portion from original bottle into second empty oven-safe glass container, decarboxylating only what they intend to use and preserving remainder in raw THCa form. Ideal for Jackson County residents dealing with severe pain or sleep issues who need full-strength relief at night.

Option 3 — Vape, auto-decarboxylation. Our RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each inhalation. Every puff delivers freshly decarboxylated cannabinoids. This is fastest-onset RSO delivery method available. For Jackson County residents experiencing breakthrough pain or acute anxiety that needs immediate relief.

Conversion chemistry: THCa has molecular weight of 358.47 g/mol. Conversion ratio is approximately 1 milligram THCa = 0.877 milligrams delta-9 THC after decarboxylation, reflecting loss of CO₂ molecule during reaction.

This design puts potency decision entirely in customer’s hands — aligning with Rick Simpson’s principle that patients should control their own medicine, but implementing that principle through actual product chemistry rather than one-size-fits-all approach.

Solvent-Free Production

Our RSO is not extraction product in traditional sense. It is formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in controlled production environment. No naphtha. No isopropyl alcohol. No butane. No extraction solvents are present in finished product.

This approach eliminates residual solvent risk that is one of most significant safety concerns with traditional RSO production.

Product uses organic MCT oil (medium-chain triglycerides) as carrier base. MCT oil is food-grade lipid carrier that facilitates cannabinoid absorption through sublingual tissue and provides neutral taste profile — significant improvement over tar-like consistency and solvent-residual odor of traditional RSO.

Third-party lab testing covers cannabinoid potency, terpene profile, and safety panels including pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on request and accessible through our website.

The Broader OilWell Product Portfolio

Beyond RSO, we produce range of cannabinoid products, each developed from formulation knowledge Colin built over Bentley’s ten-year journey and his own experience with PTSD and benzo withdrawal.

Asshole Peach — Our most popular product. Asshole Peach is carefully formulated experience designed to provide euphoric, long-lasting sensation. It is particularly favored by veterans for its ability to relieve pain and PTSD symptoms without being overly aggressive. For Jackson County veterans who’ve served in Afghanistan, Iraq, or other deployments, this formulation addresses the specific trauma patterns we see in rural Colorado veteran communities.

Peace Gummies — Developed directly from Colin’s own experience with PTSD and benzodiazepine addiction. Peace Gummies helped him quit Xanax cold turkey. Formula is also available in vape form for quick relief — Colin personally uses vape to manage his insomnia and severe PTSD on ongoing basis. Jackson County residents struggling with pharmaceutical dependence have a pathway forward that doesn’t require traveling to urban treatment centers.

Custom creations — We offer custom-made products tailored to specific needs of individual customers. Whether specific cannabinoid ratios, particular delivery formats, or formulations for unique health circumstances, we design targeted products on request. This includes formulations for vegans, diabetics, and those with specific dietary or health needs. For Jackson County’s tight-knit community where everyone’s needs are a little different, this personalized approach matters.

Two Product Formats

We offer RSO formula in two delivery formats, each designed for different use cases and pharmacokinetic profiles.

RSO Sublingual Oil — $129.99

• 30 mL bottle (1 fl oz)
• 16,590 mg total cannabinoids (553 mg per mL)
• Seven cannabinoids: CBD 4,500 mg, CBG 3,000 mg, delta-8 THC 6,000 mg, THCa 1,500 mg, delta-9 THC 90 mg, CBN 750 mg, CBC 750 mg
• Live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene
• Organic MCT oil base
• Graduated dropper for precise dosing in 0.1 mL increments
• Onset: 15-45 minutes (sublingual absorption)
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19% (partially bypasses first-pass liver metabolism)
• Approximately 40-60 doses per bottle depending on serving size

RSO Vape Cartridge — $49.99

• 1-gram cartridge
• 900 mg+ total cannabinoids
• Same six-cannabinoid ratio as sublingual formula
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1-2 minutes (fastest delivery method)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35% (variable by inhalation technique)
• Automatic THCa decarboxylation at vaping temperature (400-450°F)

When to Use Each Format in Jackson County

Use Case	Recommended Format	Rationale	Jackson County Application
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset	Sudden back spasm while repairing fence line
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration	All-day arthritis relief during calving season
Maximum bioavailability	Sublingual	13-19% absorption	Severe inflammation from old ranch injury
Portability and discretion	Vape	Compact, no measuring	Traveling to town for supplies, need quick relief
Precise dosing control	Sublingual	0.1 mL increments	Fine-tuning dose for altitude-related sleep issues
Daytime non-psychoactive use	Sublingual (raw)	Zero impairment	Operating tractor, checking cattle, daytime ranch work
Nighttime psychoactive use	Sublingual (decarbed) or Vape	Full therapeutic strength	Severe pain preventing sleep after long ranch day

Competitive Comparison — OilWell RSO vs. Alternatives

OilWell RSO vs. Colorado Dispensary RSO

Dimension	Colorado Dispensary RSO	OilWell RSO
Cannabinoid profile	Often THC-only or limited spectrum	7 cannabinoids: CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC
CBG content	Usually minimal or none	3,000 mg
CBN content	Usually minimal or none	750 mg
Patient-controlled potency	No — always fully psychoactive	Yes — THCa non-psychoactive until heated
Access requirements	Must travel to dispensary (2-3 hours from Jackson County)	Ships directly to Jackson County address
Price for comparable potency	$60-80 per gram at dispensary	$129.99 for 16,590 mg (better value per mg)
Lab testing	Required by Colorado law	Full panel testing, COAs provided

OilWell RSO vs. Hemp CBD RSO (e.g., Lazarus Naturals)

Dimension	Lazarus Naturals RSO (10 mL, 1,000 mg)	OilWell RSO (30 mL, 16,590 mg)
Total cannabinoids	1,000 mg	16,590 mg
CBD content	~950 mg	4,500 mg
CBG content	15.5 mg	3,000 mg
CBN content	0.7 mg	750 mg
Delta-8 THC	0 mg	6,000 mg
Psychoactive option	No	Yes — via THCa decarboxylation
Price	$40-50	$129.99 (far better value)

Condition-Specific Usage Context for Jackson County

Important disclaimer: Following usage contexts are informed by cannabinoid research cited in our General Knowledge section and by OilWell’s formulation rationale. They are not medical prescriptions, not FDA-approved treatment protocols, and not substitute for professional medical care. Products have not been evaluated by FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult qualified healthcare provider before using cannabinoid products, especially if you have medical condition, are taking medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under influence of psychoactive cannabinoids.

Jackson County Ranch Work-Related Chronic Pain

• Daytime maintenance: 0.3-0.5 mL raw sublingual morning and afternoon (no impairment, anti-inflammatory support)
• Evening relief: 0.5-1.0 mL decarboxylated sublingual after ranch work (full pain relief with sleep support)
• Breakthrough pain from equipment accident/old injury: 2-3 vape puffs as needed
• Evidence context: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 activation [24], THCa COX-2 inhibition [12]
• Jackson County note: Chronic pain from decades of ranch work, equipment operation, and high-altitude physical labor is common here. Our multi-cannabinoid approach targets inflammatory pathways through multiple mechanisms.

Jackson County High-Altitude Sleep Issues

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: Delivers 50 mg CBN — dosage investigated in 2024 sleep literature
• At 1.0 mL: Delivers 25 mg CBN — above threshold associated with reduced sleep disturbance
• Evidence context: CBN sleep evidence [16][17], cannabis and sleep review literature
• Jackson County note: Altitude-related sleep disturbance affects many North Park residents. Our CBN content is specifically formulated to address sleep architecture issues common at 8,000+ feet elevation.

Jackson County Arthritis and Joint Inflammation

• Morning: 0.3 mL raw sublingual (start day with anti-inflammatory support)
• Evening: 0.5-1.0 mL decarboxylated sublingual (reduce overnight inflammation)
• During weather changes: Increase dose slightly when barometric pressure drops (common arthritis trigger at altitude)
• Evidence context: THCa COX-2 inhibition [12], beta-caryophyllene CB2 activation [24], CBD anti-inflammatory mechanisms [4]
• Jackson County note: Cold, high-altitude winters and decades of physical work create perfect storm for arthritis. Our formula’s multiple anti-inflammatory pathways address this better than single-cannabinoid products.

Jackson County Veteran PTSD and Anxiety

• Daytime functional: 0.3 mL raw sublingual — CBD and CBG address anxiety without impairment
• Evening/nighttime: 1.0 mL sublingual — full profile including CBN for sleep architecture
• Acute panic attack: 2-3 vape puffs for immediate relief
• Evidence context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage effect [20]
• Jackson County note: Many veterans have made Jackson County home for its quiet and space. Our formula was developed from Colin’s personal PTSD experience, making it uniquely suited for trauma-related symptoms.

Jackson County Depression and Isolation

• Consistent daily: 0.5 mL sublingual morning (raw or decarbed based on preference)
• During difficult periods: Increase to 1.0 mL
• Evidence context: CBD mood-supporting research, limonene’s potential mood benefits [21]
• Jackson County note: Rural isolation and long winters can affect mental health. Our multi-cannabinoid approach provides support without the pharmaceutical side effects that hit harder at altitude.

General Titration Principle for Jackson County: Start low, go slow. Jackson County residents tend to be hardy and self-reliant, but cannabinoids require careful titration due to individual variation in metabolism, especially at altitude. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Delivery and Global Accessibility to Jackson County

OilWell operates one of the only RSO delivery systems that serves rural Colorado directly. While Jackson County has no local dispensary, we ship directly to your door in Walden, Cowdrey, Rand, and Gould.

Colorado Shipping

• All Colorado addresses served via USPS Priority Mail (2-3 business days)
• Discreet packaging with no cannabis branding visible
• Tracking provided for all orders
• Temperature-stable packaging for Jackson County’s variable climate
• Signature-required option available for security
• Jackson County residents can expect delivery within 3-4 business days from Houston

Why This Matters for Jackson County

Jackson County covers 1,600 square miles but has fewer than 1,400 residents. The nearest dispensary is in Steamboat Springs (60+ miles) or Fort Collins (90+ miles). A trip for cannabis products means half-day drive, fuel costs, and time away from ranch work. Our direct-to-door shipping eliminates that burden.

International Shipping

We ship internationally and have delivered to multiple countries across multiple continents. The THCa legal framework makes this possible: because product contains less than 0.3% delta-9 THC at point of sale, it meets definition of hemp-derived product under 2018 Farm Bill and is shippable to jurisdictions with compatible hemp laws.

• All international packages include full documentation, Certificates of Analysis (COAs), and receipts for customs
• Customer responsible for verifying legality in their jurisdiction and accepts all customs and legal risk
• Contact: (832) 416-2816 or [email protected]

Significance for Jackson County Ex-Pats

Many Jackson County residents have family or business interests outside the U.S. The fact that our products can legally cross borders — unlike Rick Simpson’s oil which was Schedule I everywhere — means a cancer patient in Germany, chronic pain patient in Australia, or veteran in United Kingdom can access same clinical-strength multi-cannabinoid RSO formula that you receive in Walden.

Our PANDEM1C SEO technology — proprietary system with 14 million distinct geopolitical locations in database and over 300 AI models — drives organic search visibility across six continents, making OilWell products discoverable to international patients searching for RSO in their own language.

GENERAL KNOWLEDGE

Research Method and Evidence Weighting

This section prioritizes sources in following order: human clinical evidence, systematic reviews and meta-analyses, NIH and other institutional summaries, then mechanistic or preclinical literature when human data are sparse. That weighting matters because evidence base is not evenly distributed. CBD and delta-9 THC have strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes are still much more dependent on reviews, animal work, in vitro pharmacology, or early translational literature [1]-[29].

Institutional Baseline from NIH and Related Sources

• NCCIH states strongest established cannabinoid evidence is for certain rare epilepsies, chemotherapy-related nausea and vomiting, and appetite/weight-loss indications associated with HIV/AIDS. It notes only modest evidence for chronic pain and multiple-sclerosis-related symptoms, with many other claimed uses still in early-stage research [1].
• NCCIH emphasizes FDA has not approved cannabis plant itself for medical use, although purified CBD and synthetic THC-like drugs have specific approvals [1].
• Safety concerns repeatedly highlighted: impairment, motor vehicle crash risk, cannabis use disorder, pregnancy-related concerns, accidental pediatric exposure, contamination or labeling inaccuracy, and THC-vape lung-injury concerns [1].
• NCCIH specifically warns over-the-counter CBD products may differ from labels and that CBD has been associated with decreased alertness, gastrointestinal effects, liver-related adverse effects, and drug interactions [1].

Cannabinoids

CBD

• Evidence profile: Strongest human evidence in current formula set, especially when studied as purified product [1]-[6].
• Best supported: Purified CBD has most credible human evidence in seizure disorders [1][2].
• Anxiety research: 2024 systematic review and meta-analysis covering 316 participants across eight articles reported statistically significant anxiolytic signal, but authors stressed clinical sample remains limited and more trials needed [3].
• Pain research: 2024 systematic review of clinical and preclinical CBD monotherapy studies concluded pain literature is promising but heterogeneous, with trial quality limiting confidence [4].
• Sleep research: 2023 insomnia review found literature remains methodologically weak, with many studies relying on nonvalidated subjective measures [5].
• Safety: 2023 systematic review and meta-analysis found real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy settings [6]. NCCIH flags diarrhea, sleepiness, appetite change, mood effects, liver-function abnormalities, and drug-drug interactions [1].
• Bottom line: CBD is most evidence-developed nonintoxicating cannabinoid, but strong evidence is concentrated in few specific indications rather than broad wellness claims [1]-[6].

CBG

• Evidence profile: Mostly review-level and preclinical; human evidence sparse [7][8].
• Pharmacology: CBG is biosynthetic precursor to several major cannabinoids with distinct pharmacology from THC and CBD. Review literature describes interactions spanning cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A-related signaling, making it mechanistically interesting but not yet clinically established [7].
• Potential areas: Reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but primarily pharmacology-led hypotheses or preclinical findings [7][8].
• Caution: 2021 pharmacology review notes CBG is already being sold commercially while evidence base remains thin, meaning claims frequently outrun science [7].
• Bottom line: CBG is serious research topic, but should be described as promising minor cannabinoid with limited clinical validation rather than proven therapeutic cannabinoid [7][8].

Delta-8 THC

• Evidence profile: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11].
• Comparative pharmacology: 2022 review concluded delta-8 THC and delta-9 THC have broadly similar pharmacokinetic and pharmacodynamic behavior. Delta-8 THC is partial CB1 agonist with cannabimimetic activity, but appears less potent, likely due to weaker CB1 affinity [9].
• Public health literature: 2023 scoping review found delta-8 evidence base dominated by animal studies, product chemistry, use reports, and public-health concerns rather than strong modern human trials. Review noted reports of adverse consequences and emphasized regulatory and product-quality concerns [10].
• Manufacturing context: Recent chemistry and pharmacology review reinforces commercial delta-8 interest is tied to greater stability and easier synthesis relative to naturally scarce plant levels, part of why product-byproduct and lab-testing questions matter [11].
• Bottom line: Delta-8 THC should be treated as psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and more manufacturing-quality uncertainty than many consumers realize [9]-[11].

THCa

• Evidence profile: Important chemically and formulation-wise, but low on direct human therapeutic evidence [12].
• What it is: THCa is acidic precursor of THC and may represent large share of THC-related content in raw plant material. Key formulation issue is that THCa decarboxylates into THC during heating and can change over time during storage and processing [12].
• Psychoactivity: Major review stresses THCa itself does not produce psychoactive effects associated with THC in humans, but distinction only holds if molecule stays in acidic form and is not substantially decarboxylated [12].
• Research status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but not equivalent to established human outcomes [12].
• Bottom line: THCa best understood as highly relevant precursor molecule whose interpretation depends heavily on route, temperature, processing, and storage. Any claim about THCa needs to account for possible conversion into THC [12].

Delta-9 THC

• Evidence profile: Strongest human evidence of psychoactive cannabinoids listed, but also clearest adverse-effect burden [1][13]-[15].
• Institutionally best supported: NCCIH identifies THC-containing cannabinoid medicines as relevant to chemotherapy-related nausea and vomiting, appetite and weight loss in HIV/AIDS, and some multiple-sclerosis- and pain-related outcomes, while stressing many other uses remain uncertain [1].
• Pain evidence: 2022 systematic review of cannabis-based products for chronic pain found products with high THC content or comparable THC:CBD ratios may provide short-term pain benefit, but increased dizziness, sedation, nausea, and treatment discontinuation due to adverse events [13].
• Pharmacokinetics: Classic review literature remains useful: inhaled THC produces effects within seconds to minutes, peaks ~15-30 minutes, tapers over few hours; oral THC has later onset, later peak, longer duration, which matters for both benefit and overconsumption risk [14].
• Mental health risk: 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis or schizophrenia outcomes and cannabis use disorder, with additional concerning signals for anxiety and depression in nontherapeutic settings [15].
• Broader safety: Institutional and review literature describe anxiety or panic at high doses, tachycardia, blood-pressure changes, dependency potential, withdrawal symptoms, pregnancy concerns, accidental pediatric exposure, and vape-related lung-injury concerns [1][14][15].
• Bottom line: Delta-9 THC has legitimate therapeutic relevance in some settings, but also carries clearest intoxication, psychiatric, and dose-related safety liabilities in this document [1][13]-[15].

CBN

• Evidence profile: Weak human evidence; marketing has moved ahead of data [12][16][17].
• What marketed for: Sleep and sedation. Reputation is widespread, but clinical support far thinner than market suggests [16][17].
• Best direct review: 2021 narrative review on CBN and sleep screened 99 human-study abstracts, reviewed eight full-text articles, found no clinical trials using validated sleep questionnaires or formal polysomnography that could substantiate strong sleep-promoting claims [16].
• Broader sleep literature: 2024 updated review on cannabis and sleep concluded overall cannabinoid sleep research still doesn’t match scale of real-world use, and need for better-designed, adequately powered trials remains substantial [17].
• Chemical context: Downstream cannabinoid degradation pathways matter; review literature on THCa notes THC can degrade toward CBN under certain conditions, which helps explain why CBN often discussed in aging or oxidized cannabis chemistry contexts [12].
• Bottom line: CBN is clearest example where cultural reputation is stronger than current clinical evidence base [16][17].

CBC

• Evidence profile: Emerging, intriguing, overwhelmingly preclinical or review-based [18][19].
• Pharmacology and interest: 2024 focused review on CBC argues it has distinct pharmacodynamics, pharmacokinetics, and receptor behavior relative to better-known cannabinoids, and highlights antinociceptive, antibacterial, and anti-seizure areas as especially interesting research targets [18].
• Older literature: Review literature summarizing CBC in animal and in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, and possible neurobiological or antiproliferative relevance, but not yet strong evidence for patient-facing claims [19].
• Safety caveat: 2024 CBC review explicitly notes over-the-counter CBC products are already being sold despite little evidence establishing clinical efficacy or safety [18].
• Bottom line: CBC belongs in category of scientifically credible minor cannabinoids that deserve more research, not category of already-validated clinical actives [18][19].

Terpenes

Terpene claims need even stricter interpretation than cannabinoid claims. Much of literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models rather than controlled human studies of cannabis formulations. 2024 entourage-effect review makes this especially important: terpene bioactivity is plausible and sometimes compelling, but robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene

• Evidence profile: Largely review and preclinical, with useful safety literature [20]-[22].
• Potential activity: 2021 review describes limonene as multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory, and other possible activities, but overwhelming share of claims comes from nonhuman or non-cannabis literature [21].
• Safety note: Limonene oxidation products, especially hydroperoxides, are clinically relevant contact allergens important in patch-testing literature [22].
• Bottom line: Limonene is biologically active and widely discussed, but cannabis-specific therapeutic claims should stay conservative unless directly supported in humans [20]-[22].

Myrcene

• Evidence profile: Mostly preclinical, very limited human evidence [20][23].
• Research summary: 2021 myrcene review describes anxiolytic, antioxidant, anti-inflammatory, and analgesic properties and discusses possible mechanisms, but explicitly states human studies are lacking [23].
• Interpretation caution: Myrcene often invoked in consumer language as if it were proven sedating terpene that explains couch-lock or sleep effects. That is stronger claim than human evidence currently supports [20][23].
• Bottom line: Myrcene is plausible bioactive terpene, but compound-specific clinical claims about mood, pain, or sedation remain far ahead of definitive human proof [23].

Caryophyllene

• Evidence profile: Among most mechanistically interesting terpenes because of direct cannabinoid-system relevance, but still mostly preclinical [24].
• Why it stands out: 2021 focused review describes beta-caryophyllene as selective CB2 receptor agonist, unusual and especially relevant when discussing cannabis terpenes in pharmacologic rather than purely aromatic terms [24].
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective, and related actions repeatedly discussed in review literature, but human clinical confirmation remains limited [24].
• Bottom line: Beta-caryophyllene is arguably strongest candidate for terpene with cannabinoid-system significance, but still should not be described as clinically proven for outcomes commonly attributed to it [24].

Pinene

• Evidence profile: Promising preclinical literature, weak human clinical confirmation [20][25].
• Brain-health framing: 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, and neuroprotective signals that justify future study, but emphasized evidence is mostly preclinical and well-designed clinical trials are lacking [25].
• Interpretation caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC-related cognitive effects remain interesting hypotheses rather than settled clinical facts [20][25].
• Bottom line: Pinene deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25].

Linalool

• Evidence profile: Similar to pinene: substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].
• Research summary: Linalool repeatedly discussed in relation to stress, mood, and brain-health pharmacology. 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological and psychiatric contexts, while still emphasizing lack of robust human trials [25].
• Additional literature: Separate review literature discusses possible antidepressant mechanisms and neuropharmacologic relevance, but remains translational rather than definitive clinical story [26].
• Safety note: As with limonene, oxidized linalool hydroperoxides are recognized allergens in dermatitis literature [22].
• Bottom line: Linalool is scientifically credible as bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26].

Humulene

• Evidence profile: Translationally interesting, but still early [20][27].
• Scoping-review findings: 2024 scoping review analyzed 340 articles and found broad preclinical evidence for anti-inflammatory and other biologic effects, with some rodent work even suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].
• Interpretation caution: Those findings are valuable for hypothesis generation, but do not yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27].
• Bottom line: Humulene is one of more interesting terpene research targets in this list, but remains far from clinically settled [27].

Terpinolene

• Evidence profile: One of least clinically characterized terpenes in this file [20][28].
• Systematic-review findings: 2021 terpinolene review screened 2,449 records and included 57 studies, concluding terpinolene has range of reported biological effects but evidence base is still dominated by in silico, in vitro, and animal studies rather than human trials [28].
• Interpretation caution: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not as established compound-specific clinical effects [20].
• Bottom line: Terpinolene is biologically interesting, but among listed terpenes it remains especially underdeveloped clinically [20][28].

Research Limits and Interpretation

• Evidence base is highly uneven. CBD and delta-9 THC can support most detailed human-facing statements; rest require more caution [1]-[29].
• Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not interchangeable. One common error in cannabis writing is letting evidence from one category stand in for another.
• Minor cannabinoids and terpenes are commercially interesting precisely because they are underexplored, but that also means claims around them often become inflated.
• Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, and dose variability all materially affect interpretation in real-world products [1][10][11][14].
• For THCa in particular, chemistry is destiny: storage and heating can change actual exposure profile by converting acidic cannabinoids into neutral cannabinoids such as THC [12].

Common Overstatements to Avoid

Overstatement: CBN is clinically proven sleep cannabinoid.
More accurate: Specific sleep evidence for CBN remains weak and dated, with no strong validated-trial base yet identified [16][17].

Overstatement: Myrcene is proven human sedative that reliably explains couch-lock.
More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23].

Overstatement: Terpenes in general have proven entourage effects in patients.
More accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

Overstatement: THCa is always nonpsychoactive.
More accurate: THCa itself is not THC, but heating and processing can convert THCa into THC, changing effective exposure [12].

Overstatement: Delta-8 THC is safe because it is hemp-derived.
More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

Practical Takeaways for Jackson County

• Most evidence-developed actives in these formulas are CBD and delta-9 THC.
• Delta-8 THC is not trivial or purely mild ingredient; it is psychoactive cannabinoid with less robust safety and efficacy characterization than delta-9 THC.
• THCa meaningfully changes with processing and should not be interpreted same way in raw, gently handled, and heated formats.
• CBG, CBN, and CBC are scientifically credible but clinically immature compared with CBD and THC.
• Listed terpenes are likely highly relevant to aroma, flavor, and potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully and only where directly supported.

RSO SUBLINGUAL OIL FORMULA

Complete Open-Source Formula — Published for Jackson County DIY Community

Cannabinoid	Amount
CBD	4,500 mg
CBG	3,000 mg
Delta-8 THC	6,000 mg
THCa	1,500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Total Cannabinoids	16,590 mg

Specifications:

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30 mL bottle
• Active cannabinoids per mL: 553 mg
• Carrier: Organic MCT oil
• Dosing tool: Graduated dropper (0.1 mL increments)

Conversion Notes for Jackson County DIY Makers:

• To replicate this formula, source individual cannabinoid distillates from reputable suppliers
• Mix in order: MCT oil base, then cannabinoid distillates, then terpene blend
• Use precise scale (0.01g accuracy) for cannabinoid measurements
• Terpene blend should be added last at 5% by total volume (1.5 mL for 30 mL batch)
• Mix thoroughly and store in amber glass dropper bottle

Price: $129.99 for Jackson County customers (includes shipping)

RSO VAPE CARTRIDGE FORMULA

Complete Open-Source Formula — Published for Jackson County DIY Community

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

Specifications:

• Live Terpenes: 5%+
• Format: 1 Gram cartridge
• 510-thread universal battery compatibility
• Total cannabinoids: 900+ mg

Conversion Notes for Jackson County DIY Makers:

• To replicate this formula, source individual cannabinoid distillates
• Mix in order: base distillate blend, then terpene blend
• Terpene blend should be added last at 5% by total weight (0.05g for 1g batch)
• Use precise scale for all measurements
• Fill into authentic CCELL or equivalent 510-thread cartridge

Price: $49.99 for Jackson County customers (includes shipping)

TERPENE PROFILE (BOTH PRODUCTS)

Seven-Terpene Blend — Consistent Across Sublingual and Vape

• Limonene (citrus-bright, mood elevation)
• Myrcene (earthy, calming)
• Caryophyllene (β-caryophyllene — pepper/spice, CB2 activation)
• Pinene (forest-fresh, clarity)
• Linalool (floral/lavender, calm)
• Humulene (earthy, woody, anti-inflammatory)
• Terpinolene (piney, fruity, sparkling complexity)

Jackson County Terpene Sourcing Note:
All terpenes are botanically-derived (non-cannabis) to ensure consistency and avoid cannabis-material legal complexities. However, molecular structure is identical to cannabis-derived terpenes.

How to Order in Jackson County

Online: Visit oilwellcbd.com and select your products. At checkout, enter your Jackson County address (Walden, Cowdrey, Rand, Gould, or rural route). USPS Priority Mail delivers within 3-4 business days.

Phone: Call (832) 416-2816. We’ll answer questions about products, dosing, and shipping to Jackson County. We’re available Monday-Thursday 10 AM-7 PM, Friday-Saturday 10 AM-10 PM, Sunday 10 AM-4 PM (Central Time).

Email: [email protected] — we respond within 24 hours, often faster.

Questions to Ask When Ordering:

• “I’m in Jackson County at 8,200 feet elevation — will altitude affect how I respond?” (Yes, metabolism can differ at altitude — we recommend starting with lower dose)
• “I need daytime relief without impairment for ranch work” (Choose raw sublingual option)
• “I have chronic pain from old rodeo injury” (Start with 0.5 mL sublingual, increase as needed)
• “I’m a veteran with PTSD” (Consider both sublingual for maintenance and vape for breakthrough)

Jackson County Resources and Considerations

Local Healthcare Integration:

• North Park Medical Clinic (Walden) — We encourage discussing cannabinoid use with your provider. Our COAs provide clinical documentation they need.
• Jackson County Public Health (Walden) — Our products meet all Colorado Department of Public Health requirements for hemp-derived products.
• Veteran Support: Jackson County has strong veteran community. Our formulations were developed by a veteran (Colin’s PTSD experience) specifically for trauma-related symptoms.

Altitude Considerations for Jackson County:
At 7,800-9,000 feet elevation, Jackson County residents have unique metabolic considerations:

• Slower metabolism of certain compounds
• Increased sensitivity to dehydration (cannabinoids can have mild dehydrating effects)
• Altitude-related sleep disruption may respond differently to CBN
• Recommendation: Start at 75% of suggested dose for first week, assess effects, then adjust

Weather and Delivery:
Jackson County’s harsh winters can delay mail delivery. We ship with temperature-stable packaging to prevent freezing, but recommend ordering during weather windows when possible.

Community Values:
Jackson County is built on self-reliance, neighbor-helping-neighbor, and skepticism of outsiders promising easy solutions. We respect that. Our open-source formula publication, third-party testing, and refusal to make unsupported claims align with your values. We’re not here to replace your work ethic or community bonds — we’re here to provide tool that might help when everything else has fallen short.

Economic Accessibility:
We understand Jackson County’s economy is based on ranching and seasonal tourism. Our open-source formulas mean that if $129.99 is beyond your budget, you can source ingredients and make your own version using our exact specifications. That’s not a marketing gimmick — that’s our commitment to accessibility.

Final Thoughts for Jackson County

Rick Simpson started his journey because the medical system failed him, and he believed people deserved access to alternatives. In Jackson County, where the nearest specialist might be 100 miles away and the local clinic has limited resources, that belief resonates deeply.

But Simpson’s method — crude extraction, unknown potency, toxic solvents, and unsupported cure claims — is not the answer. Not for Jackson County. You deserve better. You deserve precision, safety, transparency, and honesty about what works and what doesn’t.

OilWell’s RSO is our answer to that need. It’s built on a decade of loving a dog back to health. It’s built on personal experience with pharmaceutical failure and cannabinoid success. It’s built on seven ABC13 features where we chose honesty over hype. It’s built on 29 peer-reviewed citations that keep us accountable.

We can’t promise cures. We won’t promise miracles. But we can promise this: every cannabinoid amount is exactly what we say it is. Every terpene is included for a reason. Every product is tested for safety. And if you can’t afford it, we’ll give you the recipe to make it yourself.

That’s the OilWell promise to Jackson County. That’s what we learned in the Borderplex and perfected in the Texas Medical Center. And that’s what we’re bringing to North Park.

OilWell Cannabis Contact Information

• Website: https://oilwellcbd.com/
• Phone: (832) 416-2816
• Email: [email protected]
• Hours: Monday-Thursday 10 AM-7 PM CT, Friday-Saturday 10 AM-10 PM CT, Sunday 10 AM-4 PM CT
• Address: 810 Richmond Ave, Houston, TX 77006
• Instagram: @oilwellcbd

Jackson County Delivery Address: We ship to all addresses in Walden (80480), Cowdrey (80434), Rand (80473), Gould (80434), and rural routes throughout Jackson County.

Age Requirement: 21+ for all RSO products

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult your healthcare provider before use, especially if you are pregnant, nursing, have a medical condition, or are taking medications. Keep out of reach of children. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Legal Notice: Buyer is responsible for checking local laws. OilWell assumes no legal responsibility for customer’s use or decarboxylation decisions. Product is void where prohibited by law. Colorado residents: This product is legal under Colorado law and the 2018 Farm Bill. You are responsible for compliance with any local Jackson County ordinances.